258 related articles for article (PubMed ID: 28438697)
1. Predicting drug loading in PLA-PEG nanoparticles.
Meunier M; Goupil A; Lienard P
Int J Pharm; 2017 Jun; 526(1-2):157-166. PubMed ID: 28438697
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers.
Gref R; Quellec P; Sanchez A; Calvo P; Dellacherie E; Alonso MJ
Eur J Pharm Biopharm; 2001 Mar; 51(2):111-8. PubMed ID: 11226817
[TBL] [Abstract][Full Text] [Related]
3. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled filomicelles prepared from polylactide/poly(ethylene glycol) block copolymers for anticancer drug delivery.
Jelonek K; Li S; Wu X; Kasperczyk J; Marcinkowski A
Int J Pharm; 2015 May; 485(1-2):357-64. PubMed ID: 25796125
[TBL] [Abstract][Full Text] [Related]
5. Novel multi-biotin grafted poly(lactic acid) and its self-assembling nanoparticles capable of binding to streptavidin.
Yan H; Jiang W; Zhang Y; Liu Y; Wang B; Yang L; Deng L; Singh GK; Pan J
Int J Nanomedicine; 2012; 7():457-65. PubMed ID: 22334778
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
[TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
[TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
9. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
[TBL] [Abstract][Full Text] [Related]
10. Defining the drug incorporation properties of PLA-PEG nanoparticles.
Govender T; Riley T; Ehtezazi T; Garnett MC; Stolnik S; Illum L; Davis SS
Int J Pharm; 2000 Apr; 199(1):95-110. PubMed ID: 10794931
[TBL] [Abstract][Full Text] [Related]
11. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
12. Drug-polymer interactions at water-crystal interfaces and implications for crystallization inhibition: molecular dynamics simulations of amphiphilic block copolymer interactions with tolazamide crystals.
Gao Y; Olsen KW
J Pharm Sci; 2015 Jul; 104(7):2132-41. PubMed ID: 26045147
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
[TBL] [Abstract][Full Text] [Related]
14. Molecular Insight into Drug-Loading Capacity of PEG-PLGA Nanoparticles for Itraconazole.
Wilkosz N; Łazarski G; Kovacik L; Gargas P; Nowakowska M; Jamróz D; Kepczynski M
J Phys Chem B; 2018 Jul; 122(28):7080-7090. PubMed ID: 29927603
[TBL] [Abstract][Full Text] [Related]
15. A novel FK506 loaded nanomicelles consisting of amino-terminated poly(ethylene glycol)-block-poly(D,L)-lactic acid and hydroxypropyl methylcellulose for ocular drug delivery.
Liu D; Wu Q; Chen W; Lin H; Zhu Y; Liu Y; Liang H; Zhu F
Int J Pharm; 2019 May; 562():1-10. PubMed ID: 30878586
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
17. A method to Quantify the Affinity of Cabazitaxel for PLA-PEG Nanoparticles and Investigate the Influence of the Nano-Assembly Structure on the Drug/Particle Association.
Diou O; Greco S; Beltran T; Lairez D; Authelin JR; Bazile D
Pharm Res; 2015 Oct; 32(10):3188-200. PubMed ID: 25899077
[TBL] [Abstract][Full Text] [Related]
18. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
19. Solubility enhancement and in vitro evaluation of PEG-b-PLA micelles as nanocarrier of semi-synthetic andrographolide analogue for cholangiocarcinoma chemotherapy.
Puntawee S; Theerasilp M; Reabroi S; Saeeng R; Piyachaturawat P; Chairoungdua A; Nasongkla N
Pharm Dev Technol; 2016; 21(4):437-44. PubMed ID: 25738423
[TBL] [Abstract][Full Text] [Related]
20. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.
Bazile D; Prud'homme C; Bassoullet MT; Marlard M; Spenlehauer G; Veillard M
J Pharm Sci; 1995 Apr; 84(4):493-8. PubMed ID: 7629743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
